Cointime

ID Genomics

company

About

ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens.

  • 1 - 10

Highlights

Total Funding Amount
$3.30M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
$3M
Industries
Biotechnology,Genetics,Health Diagnostics,Medical
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens. We provide fast, high-resolution, large- or small-scale clonal identification for clinical microbiology, reference and academic research laboratories, using expanded multi-locus sequence typing (MLST), genome-wide polymorphism annotation, customized phylogenetic and genomic analysis and database creation.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$3.30M
ID Genomics has raised a total of $3.30M in funding over 2 rounds. Their latest funding was raised on Aug 24, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 24, 2021 Grant $300K 1 National Institutes of Health — Detail
May 2, 2016 Grant $3M 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
ID Genomics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
เนื้อหา
บริษัท